Bone Marrow TransplantationHematopoietic Stem Cell TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsStem Cell TransplantationTransplantation, AutologousGraft vs Host DiseaseTransplantation ConditioningBone and BonesStem CellsWhole-Body IrradiationHematopoietic Stem CellsLiver TransplantationPeripheral Blood Stem Cell TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalLeukemiaHematologic NeoplasmsBusulfanAnemia, AplasticHistocompatibility TestingBone Marrow PurgingTreatment OutcomeKidney TransplantationBone Marrow DiseasesHistocompatibilityRecurrenceCyclophosphamideCombined Modality TherapyHematopoiesisTransplantation, IsogeneicRemission InductionBone Marrow ExaminationImmunosuppressive AgentsLeukemia, Myeloid, AcuteBone RemodelingMice, Inbred C57BLTime FactorsMesenchymal Stem Cell TransplantationCell DifferentiationCord Blood Stem Cell TransplantationBone Marrow NeoplasmsMultiple MyelomaCell TransplantationRetrospective StudiesGraft RejectionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyHepatic Veno-Occlusive DiseaseHeart TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaRadiation ChimeraSurvival AnalysisMelphalanMyelodysplastic SyndromesLymphoma, Non-HodgkinImmunosuppressionGraft vs Leukemia EffectLymphocyte DepletionAntigens, CD34Lung TransplantationColony-Forming Units AssayHematologic DiseasesAntineoplastic Combined Chemotherapy ProtocolsHLA AntigensLeukemia, MyeloidAcute DiseaseMyeloablative AgonistsSurvival RateBone DensityT-LymphocytesHematopoietic Stem Cell MobilizationDisease-Free SurvivalLymphocyte TransfusionCells, CulturedGraft vs Tumor EffectGranulocyte Colony-Stimulating FactorFlow CytometryOrgan TransplantationSevere Combined ImmunodeficiencyFollow-Up StudiesCytarabineEmbryonic Stem CellsCyclosporineBone ResorptionCytomegalovirus InfectionsChimerismLeukocyte TransfusionChimeraGraft vs Host ReactionCarmustineMesenchymal Stromal CellsAdult Stem CellsEtoposidePrognosisCell LineageSalvage TherapyPancytopenia